Market Tracker

07/29 5:16pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

0.5856
Delayed Data
As of Jul 29
 +0.0176 / +3.10%
Today’s Change
0.39
Today|||52-Week Range
5.60
-80.15%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close0.57
Today’s open0.56
Day’s range0.55 - 0.60
Volume2,002,036
Average volume (3 months)4,969,681
Market cap$34.7M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+41.49%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book1.05

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...+0.66+2.97%
MRNSMarinus Pharmaceutic...-0.05-2.91%
NVGNNovogen Ltd-0.02-1.06%
THLDThreshold Pharmaceut...-0.01-0.99%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President &
Chief Financial Officer
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts